SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001144204-17-009094
Filing Date
2017-02-15
Accepted
2017-02-14 17:57:30
Documents
1
Group Members
MARK WAN (WAN)THREE ARCH ASSOCIATES III, L.P. (TAA III)THREE ARCH ASSOCIATES IV, L.P. (TAA IV)THREE ARCH MANAGEMENT III, L.L.C. (TAM III)THREE ARCH MANAGEMENT IV, L.L.C. (TAM IV)THREE ARCH PARTNERS III, L.P. (THE TAP III)WILFRED JAEGER (JAEGER)

Document Format Files

Seq Description Document Type Size
1 SC 13D/A v459647_sc13da.htm SC 13D/A 103509
  Complete submission text file 0001144204-17-009094.txt   105157
Mailing Address
Business Address 3200 ALPINE ROAD PORTOLA VALLEY CA 94028 6176191737
THREE ARCH PARTNERS IV LP (Filed by) CIK: 0001269801 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A

Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Subject) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86112 | Film No.: 17611601
SIC: 2834 Pharmaceutical Preparations